Home > Insider Trading > Filing (0000899243-19-012290)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1756262	Transmedics Group Inc.	TMDX	Electromedical & Electrotherapeutic Apparatus (3845)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1773661	M Edward Basile	C/O Transmedics Group, Inc. 200 Minuteman Road Andover MA 01810		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-05-06	14,314	$0.00	14,314	No	4	C	Direct
Common Stock	Acquisiton	2019-05-06	8,500	$16.00	22,814	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series F Convertible Preferred Stock	Disposition	2019-05-06	50,100	$0.00	14,314	$0.00
Common Stock	Stock Option (Right to Buy)	Disposition	2019-05-06	67,500	$0.00	19,285	$0.20
Common Stock	Stock Option (Right to Buy)	Acquisiton	2019-05-06	19,285	$0.00	19,285	$0.70

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		No	4	C	Direct
0	2026-02-16	No	4	J	Direct
19,285	2026-02-16	No	4	J	Direct

Footnotes

The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Agreement and Plan of Merger and Reorganization, by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated as of April 15, 2019 (the "Merger Agreement"), such preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of preferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of common stock of TransMedics, Inc. were converted into shares of common stock of the Issuer (the "Conversion"). The Preferred Stock has no expiration date.
The Stock Option reported herein as being disposed of is an option to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.
The option is fully vested.